BioArctic AB (publ) (BRCTF)
OTCMKTS · Delayed Price · Currency is USD
32.16
+1.54 (5.02%)
Oct 14, 2025, 3:13 PM EDT
BioArctic AB Employees
BioArctic AB had 107 employees as of December 31, 2024. The number of employees increased by 19 or 21.59% compared to the previous year.
Employees
107
Change (1Y)
19
Growth (1Y)
21.59%
Revenue / Employee
$1,643,315
Profits / Employee
$942,840
Market Cap
2.84B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 107 | 19 | 21.59% |
Dec 31, 2023 | 88 | 27 | 44.26% |
Dec 31, 2022 | 61 | 12 | 24.49% |
Dec 31, 2021 | 49 | 4 | 8.89% |
Dec 31, 2020 | 45 | 3 | 7.14% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Glass House Brands | 374 |
Elite Pharmaceuticals | 68 |
Northwest Biotherapeutics | 25 |
CytoDyn | 13 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Jushi Holdings | 1,234 |
Nuo Therapeutics | 9 |
BioArctic AB News
- 1 day ago - Leqembi® Iqlik™ (lecanemab-irmb) selected by TIME as one of the best innovations of 2025 - PRNewsWire
- 9 days ago - Leqembi® Iqlik™ (lecanemab-irmb) maintenance treatment launched in the U.S. - PRNewsWire
- 16 days ago - Leqembi® approved for IV maintenance treatment in China - PRNewsWire
- 21 days ago - Leqembi® approved for the treatment of early Alzheimer's disease in Australia - PRNewsWire
- 21 days ago - Leqembi® approved for the treatment of early Alzheimer's disease in Australia - Benzinga
- 5 weeks ago - BioArctic: Gunilla Osswald awarded Uppsala University Alumnus of the year 2025 - PRNewsWire
- 6 weeks ago - BioArctic's founders intend to divest minor part of their shareholding - PRNewsWire
- 6 weeks ago - Rolling sBLA initiated to the U.S. FDA for Leqembi® Iqlik™ (lecanemab-irmb) as a subcutaneous starting dose for the treatment of early Alzheimer's disease under Fast Track status - PRNewsWire